1,391
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Optimum INR intensity and therapeutic INR control in patients with mechanical heart valve prosthesis on warfarin oral anticoagulation at Dr George Mukhari academic hospital: a three-year retrospective study

, , , &
Pages 192-196 | Received 24 Jan 2018, Accepted 12 Apr 2018, Published online: 20 Aug 2018

References

  • Schimitt L, Speckman J, Ansel J. Quality assessment of anticoagulation dose management Comperative evaluation of measures of time in treatment range. Journal of thrombosis and thromboembolysis. 2003;15(3): 213–316. 10.1023/B:THRO.0000011377.78585.63 doi: 10.1023/B:THRO.0000011377.78585.63
  • Wieloch M, Själander A, Frykman V, et al. Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA. Eur Heart J. 2011;32(18): 2282–2289. 10.1093/eurheartj/ehr134
  • American Heart Association/American College of Cardiology. AHA/ACC Guidelines for the Management of Patients with Valvular Heart Disease: Executive Summary. Circulation 2006;114: 450–527.
  • Butchart EG, Chohlke-Barvolff CG, Antunes MJ, et al. Recommendations for the management of patients of patients after heart valve surgery. Eur Heart J. 2005;20: 263–271.
  • Butchart EG. Antithrombotic management in patients with prosthetic heart valves: A comparison of American and European guidelines. Heart. 2009;95: 430–436.
  • Roudaut R, Serr K, Lafitte S. Thrombosis of prosthetic heart valves: diagnosis and therapeutic considerations. Heart. 2007;93(1): 137–142. 10.1136/hrt.2005.071183
  • Mehta SR, Weitz JI. Warfarin after bioprosthetic aortic valve implantation. Lancet. 2012; 308:2147–2148 10.1001/jama.2012.91476
  • Mori T, Asano M, Ohtake OH, et al. Anticoagulant therapy after prosthetic heart valve replacement: Optimal PT-INR in Japanese patients. Ann Thorac Cardiovasc Surg. 2002;8: 83–87.
  • Tsai Y-T, Lee C-H, Hong G-J, et al. Long-term experience of anticoagulation therapy in Chinese patients with mechanical valves. J Med Sci. 2007;27(6): 259–264.
  • Akhtar RP, Abid PR, Zafar H, et al. Anticoagulation in patients following prosthetic heart valve replacement. Ann Thorac Cardiovasc Surg. 2009;15: 10–17.
  • Taksinachaneki S, Chaichun J, Hinwiset W, et al. Optimal PT-INR after prosthetic heart valve replacement: Queen Sirikit Heart Center’s experience. The Thai Journal of Surgery. 2010;31: 54–57.
  • Altman R, Rouvier G, Gurfinkel E, et al. Comparison of two levels of anticoagulation therapy in patients with substitutes heart valves. J Thorac Cardiovasc Surg. 191;101: 427–431.
  • Turpie AGG, Gunstensen J, Hirsh J, et al. Randomized comparison of two intensities of oral anticoagulant therapy after tissue heart valve replacement. Lancet, 1988; 1:1242–1242. 10.1016/S0140-6736(88)92070-3 doi: 10.1016/S0140-6736(88)92070-3
  • Rosendaal FR, Cannegieter SC, van der Meer FJ, et al. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost, 1993; 69(3):236–239. doi: 10.1055/s-0038-1651587
  • Poller L. International normalized ratio (INR): the first 20 years. J Thromb Haemostat. 2004;2: 849–860. 10.1111/jth.2004.2.issue-6 doi: 10.1111/j.1538-7836.2004.00775.x